Xbrane Biopharma AB (publ) (STO:XBRANE)

Xbrane Biopharma AB Statistics

Total Valuation

STO:XBRANE has a market cap or net worth of SEK 212.73 million. The enterprise value is 119.17 million.

Market Cap	212.73M
Enterprise Value	119.17M

Important Dates

The next estimated earnings date is Friday, February 20, 2026.

Earnings Date	Feb 20, 2026
Ex-Dividend Date	n/a

Share Statistics

STO:XBRANE has 20.61 million shares outstanding. The number of shares has increased by 171.10% in one year.

Current Share Class	20.61M
Shares Outstanding	20.61M
Shares Change (YoY)	+171.10%
Shares Change (QoQ)	+68.00%
Owned by Insiders (%)	16.69%
Owned by Institutions (%)	5.30%
Float	15.03M

Valuation Ratios

The trailing PE ratio is 2.12.

PE Ratio	2.12
Forward PE	n/a
PS Ratio	0.82
PB Ratio	0.36
P/TBV Ratio	0.36
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	1.19
EV / Sales	0.46
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.60

Financial Position

The company has a current ratio of 3.47

Current Ratio	3.47
Quick Ratio	0.90
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-4.26

Financial Efficiency

Return on equity (ROE) is -36.66% and return on invested capital (ROIC) is -23.11%.

Return on Equity (ROE)	-36.66%
Return on Assets (ROA)	-8.36%
Return on Invested Capital (ROIC)	-23.11%
Return on Capital Employed (ROCE)	-17.57%
Weighted Average Cost of Capital (WACC)	8.59%
Revenue Per Employee	9.99M
Profits Per Employee	3.87M
Employee Count	26
Asset Turnover	0.34
Inventory Turnover	0.29

Taxes

In the past 12 months, STO:XBRANE has paid 13.82 million in taxes.

Income Tax	13.82M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -54.17% in the last 52 weeks. The beta is 0.79, so STO:XBRANE's price volatility has been lower than the market average.

Beta (5Y)	0.79
52-Week Price Change	-54.17%
50-Day Moving Average	10.50
200-Day Moving Average	23.86
Relative Strength Index (RSI)	43.27
Average Volume (20 Days)	53,528

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, STO:XBRANE had revenue of SEK 259.70 million and earned 100.52 million in profits. Earnings per share was 4.51.

Revenue	259.70M
Gross Profit	199.60M
Operating Income	-103.12M
Pretax Income	-141.46M
Net Income	100.52M
EBITDA	-108.72M
EBIT	-103.12M
Earnings Per Share (EPS)	4.51

Balance Sheet

The company has 93.56 million in cash and n/a in debt, with a net cash position of 93.56 million or 4.54 per share.

Cash & Cash Equivalents	93.56M
Total Debt	n/a
Net Cash	93.56M
Net Cash Per Share	4.54
Equity (Book Value)	587.05M
Book Value Per Share	28.49
Working Capital	283.02M

Cash Flow

In the last 12 months, operating cash flow was -89.22 million and capital expenditures -109.96 million, giving a free cash flow of -199.18 million.

Operating Cash Flow	-89.22M
Capital Expenditures	-109.96M
Free Cash Flow	-199.18M
FCF Per Share	-9.67

Margins

Gross margin is 76.86%, with operating and profit margins of -39.71% and 38.71%.

Gross Margin	76.86%
Operating Margin	-39.71%
Pretax Margin	-54.47%
Profit Margin	38.71%
EBITDA Margin	-41.86%
EBIT Margin	-39.71%
FCF Margin	n/a

Dividends & Yields

STO:XBRANE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-171.10%
Shareholder Yield	-171.10%
Earnings Yield	47.25%
FCF Yield	-93.63%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 17, 2025. It was a reverse split with a ratio of 0.008.

Last Split Date	Oct 17, 2025
Split Type	Reverse
Split Ratio	0.008

Scores

STO:XBRANE has an Altman Z-Score of -0.54 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.54
Piotroski F-Score	4